Onconova Upbeat about the prospects of its CDK 4/6 Inhibitors!
A Clinical-stage biopharmaceutical company, Onconova Therapeutics, Inc. (NASDAQ: ONTX) is developing novel therapeutics to combat cancer. The Company is developing a pipeline of small molecule candidates that target various forms of cancers such as Solid Tumors and KRAS+ NSCLC and a RAS pathway and a...
